Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacist intervention program focused on i.v. ranitidine therapy.

J Santora1, J G Kitrenos, E R Green

  • 1Erie County Medical Center, Buffalo, NY.

American Journal of Hospital Pharmacy
|June 1, 1990
PubMed
Summary

A pharmacist program improved intravenous ranitidine (IV) use by optimizing dosage intervals and timely oral conversion. This intervention reduced inappropriate IV doses and associated costs, enhancing drug therapy appropriateness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapy of thyroid carcinoma using radioiodine].

Casopis lekaru ceskych·2001
Same author

[Palliative therapy of bone metastases using radiopharmaceuticals. Recommendations for diagnostic and therapeutic care in nuclear medicine].

Casopis lekaru ceskych·2001
Same author

Conversion of treatment from cefoxitin to ampicillin/sulbactam: experience in a university teaching hospital.

Advances in therapy·1994
Same author

Medication cart-filling time, accuracy, and cost with an automated dispensing system.

American journal of hospital pharmacy·1994
Same author

Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.

Antimicrobial agents and chemotherapy·1993
Same author

Clinical appropriateness, therapeutic equivalence, and cost of conversion of H2 antagonist therapy.

Hospital formulary·1993

Area of Science:

  • Pharmacology and Therapeutics
  • Health Services Research

Background:

  • Intravenous (IV) ranitidine use often involves inappropriate dosage intervals.
  • Delayed conversion from IV to oral ranitidine therapy can lead to suboptimal patient care and increased costs.

Purpose of the Study:

  • To describe a staff pharmacist intervention program aimed at optimizing IV ranitidine therapy.
  • To evaluate the program's impact on dosage interval appropriateness and timely conversion to oral therapy.

Main Methods:

  • A prospective study involving pharmacist review of patient records receiving IV ranitidine.
  • Baseline data collection on dosage interval appropriateness and oral conversion timing.
  • Implementation of pharmacist recommendations for IV dosage adjustments and oral conversion.

Related Experiment Videos

Main Results:

  • During the baseline phase, 49 of 139 patients had inappropriate IV dosage intervals.
  • In the intervention phase, pharmacist recommendations led to improved IV dosage interval appropriateness and a higher rate of appropriate conversion to oral therapy (70% vs. 57%).
  • The program identified and reduced the number of inappropriate IV doses administered, resulting in cost savings.

Conclusions:

  • A pharmacist-led intervention program can effectively improve the appropriate use of IV ranitidine.
  • The program demonstrated significant cost savings and promoted timely and appropriate drug therapy transitions.